Allosteric MEK inhibitors act on BRAF/MEK complexes to block MEK activation
- 7 September 2021
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 118 (36)
Abstract
Significance: Drugs that inhibit specific kinases now represent one of the main classes of targeted therapies. A majority of drug development efforts in this space focus on a given kinase in isolation as the target. However, our work demonstrates that in the context of the RAF/MEK/ERK pathway, the relevant target for compounds developed as allosteric MEK inhibitors (MEKi) is not free MEK but RAF/MEK complexes. Because signaling through this pathway is essential in normal tissues, indiscriminate blockade of all MEK activity is not tolerated. Our findings imply that selective inhibition of specific RAF/MEK complexes is an accessible route for development of new MEKi, and they provide a biophysical foundation for better understanding and applying current clinical agents.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (P50CA165962)
- HHS | NIH | National Cancer Institute (R35CA242461)
- HHS | NIH | National Cancer Institute (P01CA154303)
This publication has 49 references indexed in Scilit:
- Towards automated crystallographic structure refinement with phenix.refineActa Crystallographica Section D Structural Biology, 2012
- C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12DCancer Discovery, 2011
- c-Raf, but Not B-Raf, Is Essential for Development of K-Ras Oncogene-Driven Non-Small Cell Lung CarcinomaCancer Cell, 2011
- Features and development of CootActa Crystallographica Section D Structural Biology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- xia2: an expert system for macromolecular crystallography data reductionJournal of Applied Crystallography, 2009
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004